Insulin Pumps and Type 2 Diabetes
Researchers found that insulin pump therapy may benefit people with type 2 diabetes on insulin who have trouble meeting blood glucose goals using multiple daily injections. The study, funded by insulin pump manufacturer Medtronic, followed 331 people with type 2 diabetes who, despite taking at least three shots a day, had unhealthy A1C levels—a measure of overall blood glucose control—of between 8 and 12 percent. Participants were randomly assigned to either use a pump or continue with the shots. After six months, A1C levels had dropped by 1.1 percentage points with the pump versus just 0.4 with injections. Severe low blood glucose episodes were rare in both groups. Most private insurance plans in the United States cover pump therapy for both type 1 and type 2 diabetes, but Medicare is more restrictive.
Source: The Lancet, published online July 3, 2014